SCHEMBL2178059

SCHEMBL2178059

COc1ccc2cc(-c3ccnc(NCc4ccccn4)n3)cc(N3CCNCC3)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.46
IGF1R P08069 1/20 0.42
FGFR1 P11362 1/20 0.42
KDR P35968 1/20 0.42
CCNT1 O60563 2/20 0.41
CCNA2 P20248 2/20 0.41
CDK2 P24941 2/20 0.41
CDK9 P50750 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ALPL P05186 1/20 0.41
ALPG P10696 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
DYRK1A Q13627 3/20 0.40
CLK4 Q9HAZ1 3/20 0.40
DYRK1B Q9Y463 3/20 0.40
MKNK1 Q9BUB5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179122 0.93 OGA (0.44) NCF1CCNT1CCNA2CDK2CDK9
SCHEMBL2177503 0.90 PIK3CA (0.47) IGF1RFGFR1KDRCCNT1CDK9
SCHEMBL2182169 0.88 DYRK1A (0.53) NCF1CDK2DYRK1ACLK4DYRK1B
SCHEMBL2179390 0.87 NCF1 (0.46) NCF1CCNT1CCNA2CDK2CDK9
SCHEMBL10272914 0.87 DYRK1A (0.50) NCF1DYRK1ACLK4DYRK1BMKNK1
SCHEMBL2178964 0.86 NCF1 (0.45) NCF1CCNT1CCNA2CDK2CDK9
Hydrochloric Acid SCHEMBL2177661 0.86 DYRK1A (0.49) NCF1DYRK1ACLK4DYRK1BMKNK1
SCHEMBL2175103 0.85 NCF1 (0.48) NCF1KDRCCNT1CCNA2CDK2
SCHEMBL2181055 0.85 CLK4 (0.48) NCF1CDK2KDM4EALDH1A1TSHR
SCHEMBL2176027 0.84 NCF1 (0.54) NCF1CCNT1CCNA2CDK2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP NCF1 272/4885IGF1R 3575/4885FGFR1 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.